Enochian Biosciences Inc (NASDAQ:ENOB) shares are trading lower Wednesday after Hindenburg Research issued a bearish report on the company. Hindenburg noted that Gumrukcu is not only the co-founder of ...
Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results